top of page

CHO-K1/Human GPR39 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0244A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


GPR39 is a G protein-coupled receptor (GPCR) widely recognized as a key zinc ion (Zn²⁺) sensor . It is broadly expressed in the pancreas, gastrointestinal tract, liver, adipose tissue, and the central nervous system (e.g., cerebral cortex, hippocampus, and amygdala) . Its primary function is to mediate Zn²⁺ signaling, participating in the regulation of various physiological processes such as insulin secretion, gastrointestinal motility, epithelial repair, neuronal function, and anti-inflammatory responses . Dysregulation of GPR39 is associated with diseases including diabetes, depression, obesity, and certain cancers, making it a potential therapeutic target .

 

Screeningbio’s CHO-K1/Human GPR39 cell line overexpress GPR39 receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

GPR39

Accession Number

NM_001508 (Hs)

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data


CHO-K1/Human GPR39 Agonist Assay. CHO-K1/Human GPR39 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
CHO-K1/Human GPR39 Agonist Assay. CHO-K1/Human GPR39 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


GPR39 is a G protein-coupled receptor (GPCR) widely recognized as a key zinc ion (Zn²⁺) sensor . It is broadly expressed in the pancreas, gastrointestinal tract, liver, adipose tissue, and the central nervous system (e.g., cerebral cortex, hippocampus, and amygdala).


Its primary function is to mediate Zn²⁺ signaling, participating in the regulation of various physiological processes such as insulin secretion, gastrointestinal motility, epithelial repair, neuronal function, and anti-inflammatory responses.


Dysregulation of GPR39 is associated with diseases including diabetes, depression, obesity, and certain cancers, making it a potential therapeutic target.

 



Product Documentation



Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page